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In this study, we retrospectively reviewed the experiences at our single institute in the treatment of
malignant extrinsic ureteral obstruction (MUO) using ureteral stents to investigate the clinical outcomes and
the predictive factors of stent failure. In 52 ureters of 38 patients who had radiologically signiﬁcant
hydronephrosis due to MUO, internal ureteral stents (The BARD○R INLAYTM ureteral stent set) were
inserted. The median follow-up interval after the initial stent insertion was 124.5 days (4-1,120). Stent
failure occurred in 8 ureters (15.4%) of the 7 patients. The median interval from the ﬁrst stent insertion to
stent failure was 88 days (1-468). A Cox regression multivariate analysis showed that the signiﬁcant
predictors of stent failure were bladder invasion. Based on the possibility of stent failure, the adaptation of
the internal ureteral stent placement should be considered especially in a patient with MUO combined with
bladder invasion.
(Hinyokika Kiyo 63 : 503-507, 2017 DOI : 10.14989/ActaUrolJap_63_12_503)
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緒 言
悪性腫瘍の進展による壁外性尿管閉塞（malignant
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Unilateral (left) 9 (23.7)
Unilateral (right) 12 (31.6)
Bilateral 17 (44.7)
Cancer therapy after the insertion of a stent
Operation 1 (2.6)
Chemotherapy or endocrine therapy 18 (47.4)
Radiation or chemoradiation 2 (5.2)













Malignant lymphoma 1 (2.6)
Unknown 1 (2.6)
泌62,08,0◆-1


















フォローとなった．38例（52尿管）中， 7 例（ 8 尿
管）においてステント不全を認めた． 2例（ 2尿管）
に対し腎瘻造設術が施行され， 6尿管が外ステントで
ある single-J ステントに変更され，その内 5尿管が再
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Table 2. Univariate analysis of variables for prediction of stent in 52 ureters
Variables Category No p-value Hazard ratio (95％ conﬁdence interval)
Bladder invasion Yes/No 8/44 ＜0.001 11.68 (3.22-86.36)
Hygronephrosis grade
Grade 1 or 2 37
0.04 5.52 (1.10-27.61)
Grade 3 or 4 15
Patient’s age ≧67/＜67 26/26 0.40 0.54 (0.12-2.32)



















Peritoneal dissemination Yes/No 20/32 0.97 1.03 (0.20-5.43)
Therapy after the insertion of a stent Best supportive care/or not 38/68 0.76 0.78 (0.16-3.93)
Gender Male/Female 26/26 0.95 1.04 (0.25-4.21)
Table 3. Multivariate analysis of variables for prediction of stent in 52 ureters
Variables Caterory No p-value Hazard ratio (95％ conﬁdence interval)
Bladder invasion Yes/No 8/44 0.005 11.62 (2.06-65.49)
Hygronephrosis grade
Grade 1 or 2 37
0.24 2.82 (0.50-15.97)
Grade 3 or 4 15
泌62,08,0◆-2
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の内ステント挿入前の血清 Cr 値が 4 mg/dl 以上で






















1) 五十嵐 学，高橋 聡，田中俊明，ほか : 進行癌
による上部尿路閉塞症例に対する尿管ステント留
置の意義．臨泌 64 : 149-154，2010
2) 麦谷荘一，高橋 聡 : 慢性尿路閉塞疾患に対する
尿管ステント留置の適応と成績．Jpn J Endourol
27 : 56-58, 2014
3) 高橋 聡，麦谷荘一 : 尿路ステント・ガイドワイ
ヤーの種類．Jpn J Endourol 27 : 48-55, 2014
4) 竹原浩介，大仁田 亨，望月保志，ほか : 婦人科
癌および消化器癌による尿管閉塞に対する尿管ス
テント留置術の検討．泌尿紀要 60 : 13-16，2014
5) Sountoulides P, Mykoniatis I and Dimasis N : Palliative
management of malignant upper urinary tract obstruc-
tion. Hippokratia 18 : 292-297, 2014
6) Joshi HB, Adams S, Obadeyi OO, et al. : Nephro-
stomy tube or‘JJ’ureteric stent in ureteric obstruc-
tion : assessment of patient perspectives using quality-
of-life survey and utility analysis. Eur Urol 39 : 695-
701, 2001
7) Pavlovic K, Lange D and Chew BH : Stents for malig-
nant ureteral obstruction. Asian J Urol 3 : 142-149,
2016
8) Ganatra AM and Loughlin KR : The management of
malignant ureteral obstruction treated with ureteral
stents. J Urol 174 : 2125-2128, 2005
9) Wang JY, Zhang HL, Zhu Y, et al. : Predicting the
failure of retrograde ureteral stent insertion for
managing malignant ureteral obstruction in outpa-
tients. Oncol Lett 11 : 879-883, 2016
10) 池端良紀，高橋 敦，新海信雄，ほか : 悪性疾患
による尿管閉塞に対する尿管ステント留置後無効
となる予測因子の検討．Jpn J Endourol 26 : 131-
134, 2013
11) 駒井好信，河野眞吾，布施 望，ほか : 進行性消
化器癌による尿管閉塞に対する留置後尿管ステン
ト不全の予測因子．泌尿器外科 27 : 1639-1644，
2014
12) Chung SY, Stein RJ, Landsittel D, et al. : 15-year
experience with the management of extrinsic ureteral
obstruction with indwelling ureteral stent. J Urol 172 :
592-595, 2004
13) McCullough TC, May NR, Metro MJ, et al. : Serum
creatinine predicts success in retrograde ureteral stent
泌尿紀要 63巻 12号 2017年506
placement in patients with pelvic malignancies.
Urology 72 : 370-373, 2008
14) Yossepowitch O, Lifshitz DA, Dekel Y, et al. :
Predicting the success of retrograde stenting for
managing ureteral obstruction. J Urol 166 : 1746-
1749, 2001
15) Kamiyama Y, Matsuura S, Kato M, et al. : Stent
failure in the management of malignant extrinsic
ureteral obstruction : risk factors. Int J Urol 18 : 379-
382, 2011
16) Yossepowitch O, Lifshitz DA, Dekel Y, et al. : Pre-
dicting the success of retrograde stenting for managing
ureteral obstruction. J Urol 166 : 1746-1749, 2001
(Accepted on August 18, 2017)
Received on March 13, 2017
松浦，ほか : 尿管ステント・悪性腫瘍による尿管狭窄 507
